Related Experiment Video
Updated: Jan 24, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Identification of potential therapeutic target genes in mouse mesangial cells associated with diabetic nephropathy
Xin Mou1, Di Yi Zhou1, Ying Hui Liu1
1Department of Endocrinology, Zhejiang Integrated and Western Medicine Hospital, Hangzhou, Zhejiang 310003, P.R. China.
Abstract:
The aim of the present study was to identify genes under the effect of transforming growth factor-β (TGF-β1), high glucose (HG) and glucosamine (GlcN) in MES-13 mesangial cells and elucidate the molecular mechanisms of diabetic nephropathy (DN). The gene expression datasets GSE2557 and GSE2558 were downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were independently screened using the GEO2R online tool. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed using the Database for Annotation, Visualization, and Integrated Discovery. The protein-protein interaction (PPI) network was constructed using the Search Tool for the Retrieval of Interacting Genes and Cytoscape software. The hub genes were identified by the NetworkAnalyzer plugin. Overlapping genes were subjected to molecular docking analysis using SystemsDock. A total of 202 upregulated and 158 downregulated DEGs from the HG-treated groups, 138 upregulated and 103 downregulated DEGs from the GlcN-treated groups, and 81 upregulated and 44 downregulated DEGs from the TGF-β1-treated groups were identified. The majority of the DEGs were independently enriched in 'nucleosome assembly', 'chromatin silencing' and 'xenobiotic glucuronidation'. In addition, KEGG pathways were significantly enriched in 'systemic lupus erythematosus', 'protein processing in endoplasmic reticulum' and 'aldarate metabolism pathway', and 'TNF signaling pathway' intersected in the TGF-β1-treated and HG-treated groups. In total, eight hub genes, Jun, prostaglandin-endoperoxide synthase 2 (Ptgs2), fibronectin 1 (Fn1), cyclin-dependent kinase (Cdk)2, Fos, heat shock protein family A (Hsp70) member 5 (Hspa5), Hsp90b1 and homo sapiens hypoxia upregulated 1 (Hyou1), and three overlapping genes, Ras homolog gene family, member B (RHOB), complement factor H (CFH) and Krüppel-like factor 15 (KLF15), were selected. Valsartan with RHOB, and fosinopril with CFH and KLF15 had preferential binding activity. In conclusion, Jun, Ptgs2, Fn1, Cdk2, Fos, Hspa5, Hsp90b1, Hyou1, RHOB, CFH and KLF15 may be potential therapeutic targets for mesangial cells associated with DN, which may provide insight into DN treatment strategies.
Insights
This study identified key genes like Jun and RHOB involved in diabetic nephropathy (DN) by analyzing gene expression changes in mesangial cells. These genes may offer new therapeutic targets for treating DN.
Area of Science:
- Molecular Biology
- Genomics
- Nephrology
Background:
- Diabetic nephropathy (DN) is a major complication of diabetes, characterized by progressive kidney damage.
- Understanding the molecular mechanisms underlying DN is crucial for developing effective treatments.
Purpose of the Study:
- To identify genes affected by transforming growth factor-β (TGF-β1), high glucose (HG), and glucosamine (GlcN) in MES-13 mesangial cells.
- To elucidate the molecular mechanisms of diabetic nephropathy (DN).
Main Methods:
- Downloaded and analyzed gene expression datasets (GSE2557, GSE2558) from the Gene Expression Omnibus database.
- Screened differentially expressed genes (DEGs) using GEO2R and performed Gene Ontology and KEGG pathway enrichment analyses.
- Constructed protein-protein interaction (PPI) networks and identified hub and overlapping genes for molecular docking analysis.
Main Results:
- Identified numerous DEGs in response to TGF-β1, HG, and GlcN treatments.
- Enriched pathways included 'nucleosome assembly', 'chromatin silencing', 'xenobiotic glucuronidation', 'systemic lupus erythematosus', 'protein processing in endoplasmic reticulum', 'aldarate metabolism', and 'TNF signaling pathway'.
- Selected eight hub genes (Jun, Ptgs2, Fn1, Cdk2, Fos, Hspa5, Hsp90b1, Hyou1) and three overlapping genes (RHOB, CFH, KLF15) with potential therapeutic relevance.
Conclusions:
- Jun, Ptgs2, Fn1, Cdk2, Fos, Hspa5, Hsp90b1, Hyou1, RHOB, CFH, and KLF15 are potential therapeutic targets for mesangial cells in DN.
- These findings may offer novel insights into DN treatment strategies.
- Molecular docking revealed potential drug interactions, such as Valsartan with RHOB and Fosinopril with CFH and KLF15.
More Related Videos
Related Concept Videos
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
Therapeutic Drug Monitoring: Drug Analysis Methods
Cell Specific Gene Expression
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Therapeutic Index
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...

